During the past decade, Urology Center Las Vegas conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urology Center Las Vegas" are "Bladder Cancer" (1 trials), "Carcinoma" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Transitional Cell Cancer of the Renal Pelvis and Ureter" (1 trials) and "Transitional Cell Carcinoma" (1 trials). Many other conditions were trialed in "Urology Center Las Vegas" in a lesser frequency.

Most popular intervention types in "Urology Center Las Vegas" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "UGN-101 instillations" (2 trials) and "UGN-102" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology Center Las Vegas" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Urology Center Las Vegas". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Urology Center Las Vegas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urology Center Las Vegas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".